Director · CHAMPIONS ONCOLOGY, INC. · CHAMPIONS ONCOLOGY, INC. — Option to purchase Common Stock
Side
A
Value
$97K
Shares
20.3K
Price
$4.76
Executed
Nov 5, 2026
Disclosed
Nov 9, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 5 executedNov 9, 2026 disclosed
CSBR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+4 / 25
$97K reported value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
CHAMPIONS ONCOLOGY, INC. — Option to purchase Common Stock
Ticker
CSBR
Shares
20.3K
Price per share
$4.76
Value
$96,585
Execution date (reported)
Nov 5, 2026
Owned after transaction
20.3K shares
Days from execution to publication
4
Calculation
Value = shares × reported price per share
Shares: 20.3K
Price: $4.76
= $96,585
What this establishes
Mendelson Daniel Newman filed this Form 4 reporting a grant or award of CSBR on Nov 5, 2026. It became public on Nov 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Mendelson Daniel Newmancik:0001327897
Issuer
CHAMPIONS ONCOLOGY, INC.cik:0000771856
Revision history · 0
No field has changed since this record was first ingested.
